Tuberculosis (TB) is a disease of Health and social inequality. Not only does it disproportionately affect people from vulnerable and minority ethnic groups, but it remains one of the most stigmatized diseases globally. Often this is associated with misconceptions and fears that can lead to isolation and shame for those affected. Despite advances in medical treatment, the social stigma surrounding TB continues to be a significant barrier to diagnosis, treatment, and support for patients.
According to the World Health Organization (WHO) report, TB is the leading cause of death from an infectious disease worldwide, surpassing COVID19 and HIV. In 2022, an estimated 10.6 million people, including 5.8 million men, 3.5 million women, and 1.3 million children, fell ill with TB globally. Despite its prevalence, TB is still seen as a disease associated with shame and backwardness, effecting people physically, mentally, emotionally, and financially.

Among the struggling TB patients was Dipesh Patel, a young 27 year old man of Gujarati Indian descent from Leicester, diagnosed in July 2015.
At the time, he was 18 years old and in his final year of college. His diagnosis came as a shock, not only because TB seemed like a disease of the past but also because it came with the added burden of stigma.
Physically, the disease left him weak and frail, resulting in significant weight loss. He was admitted to Leicester Royal Infirmary, where his treatment lasted for nine months. During this time, he faced a challenging treatment regimen that caused liver complications, requiring adjustments, and ultimately prolonging his recovery. Even simple tasks, like picking up a cup of water, required monumental effort.
Dipesh described TB as debilitating, “It was really strange when you sort of lose that connection with your body in a way. It won’t do what it’s told.”
The long-term hospitalization was a significant challenge for him, particularly as it was his first extended stay away from home. He adapted to the routine of hospital life, but the experience was isolating and difficult, especially for someone so young.
The social stigma associated with TB affected Dipesh, although there was some awareness and understanding of the disease within his Gujarati Indian community due to its prevalence. Nonetheless, he initially kept his diagnosis private, only informing close friends and family, when necessary due to the stigma.
After his recovery, Dipesh chose to turn his experience into something positive by participating in the EVENT TB research study investigating how the immune system responds to TB.
Recognising the importance of this and other research to public health, Dipesh has contributed to research that is helping us to improve TB diagnosis and treatment.
His participation also provided him with reassurance, knowing that his health was being closely monitored through the study. As Dipesh put it, “What was initially a very negative, maybe devastating traumatic event, you know, you’re putting it to good use to further whatever research needs doing.”
His experience of both having TB and witnessing a loved one struggle with the same disease deepened his understanding of the critical need for awareness and prevention. To further this cause, he volunteered to participate in a film for an art installation focused on the stigma surrounding TB. This project allowed him to share his story and help raise awareness about the challenges TB patients face, particularly the social stigma that can accompany the disease.
We hope the courage Dipesh has shown in coming forwards to talk about his experience will inspire others to do the same. His actions are an important step towards overcoming the social stigma and raise the collective awareness of TB that is critical for addressing one aspect of the health inequality faced by sufferers.
Dipesh’s participation in the EVENT study is valuable for society because it is helping researchers better understand the immune response in TB, which is crucial for developing more effective ways to identify and treat those at risk of progressing from latent TB infection to active TB disease. His involvement will directly contribute to advancements that could lead to more targeted and effective TB prevention and treatment strategies.
For more information on the work of our Respiratory and Infectious Diseases theme, click here.


